Chemours Stock Target Price and Analyst Consensus
| CC Stock | USD 15.80 0.35 2.17% |
The current analyst and expert consensus on Chemours is Buy with 6 hold recommendations. The current projected Chemours target price consensus is 24.22 with 9 analyst opinions. One of the most common ways Chemours analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Chemours vendors, executives, and/or customers. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Chemours. We strongly encourage you to use your own analysis of Chemours to validate this buy or sell advice. Chemours recommendation module provides expert sentiment on the projected Chemours target price to derive its highest and lowest estimates based on target price standard deviation of 2.8504.
Lowest Forecast 22.04 | Highest Forecast 26.89 | Target Price 24.22 |
Chemours |
It's important to approach Chemours' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Chemours Target Price Consensus
Chemours target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Chemours' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 9 | Buy |
Most Chemours analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Chemours stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Chemours, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationChemours Target Price Projection
Chemours' current and average target prices are 15.80 and 24.22, respectively. The current price of Chemours is the price at which Chemours Co is currently trading. On the other hand, Chemours' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Chemours Market Quote on 25th of February 2025
Target Price
Analyst Consensus On Chemours Target Price
Chemours Analyst Ratings
Chemours' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Chemours stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Chemours' financials, market performance, and future outlook by experienced professionals. Chemours' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Chemours price targets
Chemours' stock target price is an estimate of its future price, usually made by analysts. Using Chemours' target price to determine if it is a suitable investment can be done through the following steps:- Look at Chemours' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Chemours' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Chemours Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Chemours is a key component of Chemours valuation and have some predictive power on the future returns of a Chemours.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Chemours' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Artificial Intelligence Invested few shares | |
 | Banking Invested over 30 shares | |
 | Hedge Favorites Invested over 60 shares | |
 | Corona Opportunity Invested few shares | |
 | Investor Favorites Invested over 60 shares | |
 | Dividend Beast Invested over 60 shares | |
 | Video Games Invested few shares | |
 | Driverless Cars Invested over 300 shares | |
 | Momentum Invested over 60 shares | |
 | Chemicals Invested over 30 shares | |
 | Giant Impact Invested over 20 shares |
Check out Macroaxis Advice on Chemours to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Please note, the presentation of Chemours' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Chemours' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Chemours' management manipulating its earnings.